MICHAEL JACOBS: Open Payments
NPI 1053300913 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $164 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $54 |
| Baxter Healthcare | 1 | $43 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $32 |
| Philips North America LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: OTEZLA, Hillrom - Volara System, NUPLAZID, inCourage Airway Clearance Therapy, The Cologuard Plus Collection Kit, MOUNJARO, XIFAXAN, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
